Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrontier Dev Regulatory News (FDEV)

Share Price Information for Frontier Dev (FDEV)

Share Price is delayed by 15 minutes
Get Live Data
486.50    40.00 (8.96%)
Bid:
486.00
Ask:
487.50
Spread: 1.50 (0.309%)
Market Cap: £168.98m
FDEV Live PriceLast checked at - London Stock Exchange

Intraday Frontier Dev Share Chart

Director's Holdings

10 Nov 2015 15:43

RNS Number : 2442F
Frontier Developments PLC
10 November 2015
 



10 November 2015

 

Frontier Developments plc

(the "Company")

 

Director's Holdings

 

The Company announces that following the issue of ordinary shares on 2 July 2015 David Braben's percentage shareholding changed from 53.3% to 52.996%. Following the issuance of ordinary shares on 22 October 2015, David Braben's percentage shareholding is now 52.5%. For the avoidance of doubt, David Braben's shareholding remains unchanged throughout at 17,910,953 ordinary shares.

 

Enquiries:

Frontier Developments

+44 (0)1223 394 300

David Braben, CEO

David Walsh, COO

Neil Armstrong, CFO

 

 

 

 

Numis - Nomad and Joint Broker

+44 (0)20 7260 1000

Simon Willis / Jamie Lillywhite / Rupert Krefting

 

 

 Finncap

 +44 (0) 207 220 0500

Matt Goode/Giles Rolls

 

 

 

 

Tulchan Communications

+44 (0) 207 353 4200

James Macey White/Matt Low

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSEBLFFEFFZFBL
Date   Source Headline
20th Mar 20267:00 amRNSTransaction in Own Shares
19th Mar 20267:00 amRNSDirector/PDMR Shareholding
19th Mar 20267:00 amRNSTransaction in Own Shares
18th Mar 20267:00 amRNSDirector/PDMR Shareholding
18th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSDirector/PDMR Shareholding
17th Mar 20267:00 amRNSDirector/PDMR Shareholding
17th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSDirector/PDMR Shareholding
16th Mar 20267:00 amRNSDirector/PDMR Shareholding
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSDirector/PDMR Shareholding
13th Mar 20267:00 amRNSDirector/PDMR Shareholding
13th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 20267:00 amRNSDirector/PDMR Shareholding
12th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSDirector/PDMR Shareholding
11th Mar 20267:00 amRNSDirector/PDMR Shareholding
11th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSDirector/PDMR Shareholding
10th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
9th Mar 20267:00 amRNSDirector/PDMR Shareholding
9th Mar 20267:00 amRNSTransaction in Own Shares
6th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSDirector/PDMR Shareholding
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20267:00 amRNSDirector/PDMR Shareholding
4th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20267:00 amRNSDirector/PDMR Shareholding
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20267:00 amRNSDirector/PDMR Shareholding
2nd Mar 20267:00 amRNSTransaction in Own Shares
27th Feb 20267:00 amRNSDirector/PDMR Shareholding
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSLaunch of on-market Share Buyback Programme
26th Feb 20267:00 amRNSBlock Listing Return
11th Feb 202610:45 amRNSOption Grants / PDMR Dealings
27th Jan 20263:43 pmRNSHolding(s) in Company
14th Jan 20267:00 amRNSExcellent H1 Results & full year outlook upgraded
2nd Jan 20267:00 amRNSAppointment of Chief Executive Officer
2nd Jan 20267:00 amRNSAppointment of Chief Executive Officer
16th Dec 20257:00 amRNSCEO TRANSITION
14th Nov 20251:37 pmRNSDirector/PDMR Shareholding
6th Nov 20257:00 amRNSA STRONG LAUNCH FOR JWE3 & A SEQUEL FOR PLANET ZOO
5th Nov 20258:57 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.